Tongyuankang Pharmaceutical-B (02410): Jiang Xiaolin was appointed as an independent non-executive director

Zhitong Finance App News, Tongyuankang Pharmaceutical-B (02410) announced that Mr. Jiang Xiaolin (Mr. Jiang) has been appointed as an independent non-executive director, chairman of the Board Audit Committee (Audit Committee), member of the Board's Remuneration and Assessment Committee (Remuneration Committee), and a member of the Nomination Committee (Nomination Committee) with effect from December 12, 2025.

Mr. Jiang was appointed as Chairman of the Audit Committee as well as a member of the Remuneration Committee and a member of the Nomination Committee after being appointed on December 12, 2025.

The Company also announced that with effect from December 12, 2025, Dr. Gu Hong, a non-executive director, was appointed as a member of the Audit Committee, and Dr. Li Jun, a non-executive director, will no longer serve as a member of the Audit Committee. To spend more time on other business and personal matters, Dr. Li Jun is no longer a member of the Audit Committee.